These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23979264)

  • 1. Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis.
    Satoh S; Omura S; Inoue H; Ejima E; Shimozono K; Hayashi M; Mori T; Takenaka K; Kawamura N; Numaguchi K; Mori E; Asoh A; Nakamura T; Hiyamuta K
    Heart Vessels; 2014 Sep; 29(5):659-66. PubMed ID: 23979264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic criteria for left ventricular hypertrophy in aortic valve stenosis: Correlation with echocardiographic parameters.
    Bula K; Ćmiel A; Sejud M; Sobczyk K; Ryszkiewicz S; Szydło K; Wita M; Mizia-Stec K
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12645. PubMed ID: 30896064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
    J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data).
    Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Hammer-Hansen S; Køber L; Willenheimer R; Wachtell K
    Am J Cardiol; 2011 Aug; 108(4):541-7. PubMed ID: 21624542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The strain pattern, and not Sokolow-Lyon electrocardiographic voltage criteria, is independently associated with anatomic left ventricular hypertrophy.
    Ehara S; Hasegawa T; Matsumoto K; Otsuka K; Yamazaki T; Iguchi T; Izumi Y; Shimada K; Yoshiyama M
    Heart Vessels; 2014 Sep; 29(5):638-44. PubMed ID: 24048761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis.
    Ventura JE; Tavella N; Romero C; Petraglia A; Báez A; Muñoz L
    Nephrol Dial Transplant; 2002 Oct; 17(10):1795-801. PubMed ID: 12270987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
    Kampaktsis PN; Ullal AV; Swaminathan RV; Minutello RM; Kim L; Bergman GS; Feldman DN; Singh H; Wong SC; Okin PM
    Clin Cardiol; 2018 Sep; 41(9):1246-1251. PubMed ID: 30062778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ECG criteria for left ventricular hypertrophy before and after aortic valve replacement using magnetic resonance imaging.
    Beyerbacht HP; Bax JJ; Lamb HJ; van der Laarse A; Vliegen HW; de Roos A; Zwinderman AH; van der Wall EE
    J Cardiovasc Magn Reson; 2003 Jul; 5(3):465-74. PubMed ID: 12882077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Yang Y; Ahn JM; Kang DY; Ko E; Kim S; Kim TO; Kim JH; Lee J; Lee SA; Kim DH; Kim HJ; Kim JB; Choo SJ; Park SJ; Park DW
    J Am Heart Assoc; 2022 Feb; 11(4):e023647. PubMed ID: 35112886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality.
    Sager P; Rusch A; Weber L; Breuss A; Appert S; Brenner R; Buser M; Ammann P; Rickli H; Maeder MT
    Clin Cardiol; 2024 Jan; 47(1):e24155. PubMed ID: 37740622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular hypertrophy in patients with aortic stenosis. A comparison between electrocardiography and echocardiography].
    Sonne HS; Mølgaard H; Sørensen KE; Kristensen BO
    Ugeskr Laeger; 1994 Oct; 156(41):6032-5. PubMed ID: 7992445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender difference in ventricular response to aortic stenosis: insight from cardiovascular magnetic resonance.
    Lee JM; Park SJ; Lee SP; Park E; Chang SA; Kim HK; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
    PLoS One; 2015; 10(3):e0121684. PubMed ID: 25811358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance.
    Buchner S; Debl K; Haimerl J; Djavidani B; Poschenrieder F; Feuerbach S; Riegger GA; Luchner A
    J Cardiovasc Magn Reson; 2009 Jun; 11(1):18. PubMed ID: 19486532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.